Philips receives FDA 510(k) clearance for Verida system

Royal Philips (PHG) announced it has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral CT Verida system. “With FDA clearance for Verida, we are bringing the next evolution of spectral CT to more markets,” said Dan Xu, Business Leader of CT at Philips. “By combining always-on spectral imaging with AI-powered reconstruction, Verida enables clinicians to see more, first time right, supporting faster, more informed decisions and expanding the role of CT across clinical pathways.”